We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+4.76%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$5.32B
AUM Growth
+$155M
Cap. Flow
-$100M
Cap. Flow %
-1.89%
Top 10 Hldgs %
16.3%
Holding
739
New
50
Increased
312
Reduced
249
Closed
35

Top Buys

Rank Stock Value
1
K
Kellanova
K
+$31M
2
CL icon
Colgate-Palmolive
CL
+$20M
3
MRK icon
Merck
MRK
+$18.8M
4
GLW icon
Corning
GLW
+$18.5M
5
FFIV icon
F5
FFIV
+$17.2M

Sector Composition

Rank Sector Weight
1 Healthcare 25.58%
2 Technology 13.62%
3 Financials 13.2%
4 Consumer Discretionary 9.51%
5 Industrials 7.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BMY icon
101
Bristol-Myers Squibb
BMY
$126B
$13.6M 0.26%
243,599
-41,549
-15% -$2.26M
COTY icon
102
Coty
COTY
$2.29B
$13.6M 0.25%
722,739
-1,303
-0.2% -$24.1K
MMM icon
103
3M
MMM
$87.5B
$13.3M 0.25%
76,392
+2,943
+4% +$492K
LLY icon
104
Eli Lilly
LLY
$1.06T
$13.3M 0.25%
161,386
+4,722
+3% +$385K
FDX icon
105
FedEx
FDX
$74.7B
$13.2M 0.25%
60,813
-2,383
-4% -$470K
COF icon
106
Capital One
COF
$123B
$13.2M 0.25%
159,532
-3,072
-2% -$250K
TAL icon
107
TAL Education Group
TAL
$5.74B
$13.1M 0.25%
643,800
-194,400
-23% -$3.82M
INTC icon
108
Intel
INTC
$504B
$13M 0.24%
385,025
+12,830
+3% +$459K
MKC icon
109
McCormick & Company Non-Voting
MKC
$13.5B
$12.9M 0.24%
265,334
+226,864
+590% +$11.5M
KGC icon
110
Kinross Gold
KGC
$28.3B
$12.8M 0.24%
3,143,479
+1,084,097
+53% +$4.31M
CVX icon
111
Chevron
CVX
$387B
$12.6M 0.24%
121,195
-88,788
-42% -$9.41M
ZBH icon
112
Zimmer Biomet
ZBH
$17.3B
$12.6M 0.24%
101,295
+56,021
+124% +$6.64M
ABT icon
113
Abbott
ABT
$175B
$12.6M 0.24%
258,622
-366,442
-59% -$16.6M
BA icon
114
Boeing
BA
$165B
$12.4M 0.23%
62,503
-19,386
-24% -$3.61M
ELV icon
115
Elevance Health
ELV
$82.3B
$12.3M 0.23%
65,324
+26,551
+68% +$4.77M
SCI icon
116
Service Corp International
SCI
$10.9B
$12.3M 0.23%
367,380
+25,380
+7% +$809K
SWKS icon
117
Skyworks Solutions
SWKS
$9.1B
$12.3M 0.23%
127,665
+8,328
+7% +$854K
TGT icon
118
Target
TGT
$61.1B
$12.1M 0.23%
231,591
-45,121
-16% -$2.47M
PNW icon
119
Pinnacle West Capital
PNW
$12.8B
$12M 0.23%
141,375
+119,142
+536% +$10.3M
STI
120
DELISTED
SunTrust Banks, Inc.
STI
$11.9M 0.22%
209,825
-26,152
-11% -$1.45M
KMI icon
121
Kinder Morgan
KMI
$72.9B
$11.9M 0.22%
620,890
-11,404
-2% -$227K
WB icon
122
Weibo
WB
$1.92B
$11.9M 0.22%
178,500
-30,500
-15% -$1.98M
IBM icon
123
IBM
IBM
$194B
$11.8M 0.22%
79,944
+3,336
+4% +$503K
KYNB
124
Kyntra Bio
KYNB
$28.6M
$11.7M 0.22%
14,440
-1,320
-8% -$919K
TXN icon
125
Texas Instruments
TXN
$259B
$11.5M 0.22%
149,845
+31,702
+27% +$2.54M

Similar funds

Candriam SCA's Q2 2017 Portfolio in Review

As of Q2 2017, Candriam SCA held 739 positions worth $5.32B, up 3% from $5.17B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Candriam SCA's Q2 2017 filing shows 50 new, 312 increased, 249 reduced and 35 closed positions. Its largest new stake was Raymond James Financial: 164,790 shares worth $8.81M. The largest sale was PepsiCo, an estimated $40.4M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 24% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q2 2017 buy was Raymond James Financial: 164,790 shares worth $8.81M.
  • Candriam SCA added most to Kellanova in Q2 2017, an estimated $31M increase.
  • Candriam SCA's biggest Q2 2017 reduction was PepsiCo, cutting an estimated $40.4M.
  • Candriam SCA fully exited Mead Johnson Nutrition Company in Q2 2017, selling an estimated $20.4M.
  • Candriam SCA's ten largest holdings make up 16% of its $5.32B portfolio in Q2 2017.
  • Candriam SCA opened 50 new positions and closed 35 in Q2 2017.
  • Candriam SCA's portfolio value rose 3% quarter-over-quarter to $5.32B.

Based on Candriam SCA's 13F filing for Q2 2017, filed 31 Jul 2017.